Gallic Acid Alleviates Visceral Pain and Depression via Inhibition of P2X7 Receptor

Abstract

Chronic visceral pain can occur in many disorders, the most common of which is irritable bowel syndrome (IBS). Moreover, depression is a frequent comorbidity of chronic visceral pain. The P2X7 receptor is crucial in inflammatory processes and is closely connected to developing pain and depression. Gallic acid, a phenolic acid that can be extracted from traditional Chinese medicine, has been demonstrated to be anti-inflammatory and anti-depressive. In this study, we investigated whether gallic acid could alleviate comorbid visceral pain and depression by reducing the expression of the P2X7 receptor. To this end, the pain thresholds of rats with comorbid visceral pain and depression were gauged using the abdominal withdraw reflex score, whereas the depression level of each rat was quantified using the sucrose preference test, the forced swimming test, and the open field test. The expressions of the P2X7 receptor in the hippocampus, spinal cord, and dorsal root ganglion (DRG) were assessed by Western blotting and quantitative real-time PCR. Furthermore, the distributions of the P2X7 receptor and glial fibrillary acidic protein (GFAP) in the hippocampus and DRG were investigated in immunofluorescent experiments. The expressions of p-ERK1/2 and ERK1/2 were determined using Western blotting. The enzyme-linked immunosorbent assay was utilized to measure the concentrations of IL-1β, TNF-α, and IL-10 in the serum. Our results demonstrate that gallic acid was able to alleviate both pain and depression in the rats under study. Gallic acid also reduced the expressions of the P2X7 receptor and p-ERK1/2 in the hippocampi, spinal cords, and DRGs of these rats. Moreover, gallic acid treatment decreased the serum concentrations of IL-1β and TNF-α, while raising IL-10 levels in these rats. Thus, gallic acid may be an effective novel candidate for the treatment of comorbid visceral pain and depression by inhibiting the expressions of the P2X7 receptor in the hippocampus, spinal cord, and DRG.

Long-term Pu-erh tea consumption improves blue light-induced depression-like behaviors

“…11 GA could modulate depressive behaviors and affect BBB permeability, which is related to its anti-inflammatory effect. 28,29 TPS have shown antioxidant and immune regulation effects which reduce inflammatory cytokines through an anti-inflammatory effect to inhibit the development of depression. 30 Caffeine is the most abundant alkaloid which could be absorbed through the intestinal tract and cross the BBB to modulate neurotransmitters to improve mood.…”

Efficacy and safety of Changyanning tablets in the treatment of diarrhea-predominant irritable bowel syndrome and its effect on gut microbiota：Study protocol for a multicenter, randomized, double-blind, placebo-controlled trial

“…Essential oil from Liquidambar formosana leaves has certain anti-in ammatory activity, which can ameliorates in ammatory response in lipopolysaccharideactivated mouse macrophages [31] .The remarkable clinical e cacy of CYN tablets may come from the comprehensive effect of multi-components and multi-targets of different herbs. Identi cation and analysis using liquid chromatography-tandem mass spectrometry (LC-MS) revealed that the main active components of CYN (a TCM formula) include quercetin, gallic acid, catechol, luteolin, kaempferol, etc., which possess various biological activities such as anti-in ammatory, visceral pain relief, antioxidant, alleviation of visceral hypersensitivity, and modulation of gut microbiota [32][33][34][35][36] .…”

Microglial infiltration mediates cognitive dysfunction in rat models of hypothalamic obesity via a hypothalamic-hippocampal circuit involving the lateral hypothalamic area

“…The open field test (OF) imitates unsafe surroundings, evaluates animals’ autonomous behavior, and reveals how tense the animals are ( Cheng et al, 2022 ; Hou et al, 2022 ; Wang L. P. et al, 2022 ; Wen et al, 2022 ). A 30 min dark adaptation was conducted before initiating the test.…”